Asset Publisher Asset Publisher
BBMRI.at & COVID 19
Resources from Biobanks for Research on COVID 19
COVID-19 caused by the corona virus SARS-Cov-2 represents a great challenge for our healthcare systems. The situation and the working conditions are difficult in many places and direct patient care has the highest priority.
The Medical University BBMRI.at partners are doing a great job in patient diagnosis, care and treatment. In addition, there are also research activities.towards finding ways to deal with the COVID-19 disease. Biobanks can support researchers and provide key services to them, such as:
Efficient and high-quality storage of samples in clinical and research settings;
Samples from healthy individuals, to be used as control (collected 2-3 months before outbreak in each country);
Provide guidance and standards for targeted identification, collection and conservation of important samples.
What BBMRI.at partners do
Medical University Graz with Institute of Pathology and Biobank Graz
see media report about the High Security Lab at Med Uni Graz:
Medical University of Innsbruck with Biobank Innsbruck
Medical University of Vienna with MedUniWien Biobank